Literature DB >> 1374102

Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels.

E D Anastassiou1, F Paliogianni, J P Balow, H Yamada, D T Boumpas.   

Abstract

cAMP is an intracellular second messenger that conveys inhibitory signals for T cell activation and clonal proliferation. cAMP also inhibits the production of IL-2 and IL-2R alpha-chain expression. To determine the mechanisms of this inhibition, human peripheral blood T lymphocytes were stimulated with anti-CD3 mAb, PHA, PMA, or ionomycin, alone or in combination. cAMP elevation by PGE2, cholera toxin, or the cell-permeable analogue 8-bromo-cAMP inhibited the tyrosine phosphorylation of a protein of 100 kDa. This inhibition was associated with decreased IL-2 production and IL-2R alpha expression at both the protein product and the mRNA levels. Nuclear run-off assays showed that the inhibitory effect of cAMP on IL-2 and IL-2R alpha gene expression is mediated at the transcriptional level. H-8, an inhibitor of protein kinase A, reversed the inhibitory effect of cAMP on nuclear transcription of the IL-2 gene, suggesting that this is mediated through activation of protein kinase A. Post-transcriptionally, cAMP elevation decreased the t1/2 of IL-2 mRNA by more than 50%. These data indicate that cAMP inhibits cell membrane, cytoplasmic, and nuclear events associated with T cell activation and highlight the complexities of its action of lymphocyte function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374102

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?

Authors:  M A Giembycz
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

2.  Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections.

Authors:  S Haraguchi; R A Good; M James-Yarish; G J Cianciolo; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

3.  Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infections.

Authors:  Jian Li; Udaikumar M Padigel; Phillip Scott; Jay P Farrell
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 4.  EPAC proteins transduce diverse cellular actions of cAMP.

Authors:  Gillian Borland; Brian O Smith; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

5.  Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells.

Authors:  S Gerlo; P Verdood; E L Hooghe-Peters; R Kooijman
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

6.  E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea-pig skin.

Authors:  M M Teixeira; T J Williams; P G Hellewell
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.

Authors:  Lamis Jarvinen; Linda Badri; Scott Wettlaufer; Takashi Ohtsuka; Theodore J Standiford; Galen B Toews; David J Pinsky; Marc Peters-Golden; Vibha N Lama
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  Altered gene transcription after burn injury results in depressed T-lymphocyte activation.

Authors:  A F Horgan; M V Mendez; D S O'Riordain; R G Holzheimer; J A Mannick; M L Rodrick
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

Review 9.  Eicosanoids and the immunology of cancer.

Authors:  M R Young
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

10.  Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins.

Authors:  Sreya Chattopadhyay; Sankar Bhattacharyya; Baisakhi Saha; Juni Chakraborty; Suchismita Mohanty; Dewan Md Sakib Hossain; Shuvomoy Banerjee; Kaushik Das; Gaurisankar Sa; Tanya Das
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.